Patents Assigned to KALEIDO BIOSCIENCES, INC.
  • MICROBIOME REGULATORS AND RELATED USES THEREOF
    Publication number: 20220395521
    Abstract: Compositions comprising microbiome regulators are provided, as well as methods of using the same for the modulation of the human microbiota and to treat or prevent related diseases, disorders, or conditions.
    Type: Application
    Filed: January 19, 2022
    Publication date: December 15, 2022
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Geoffrey A. von Maltzahn, John M. Geremia
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20220233560
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing pathogen levels and/or abundance and for the treatment of related diseases.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 28, 2022
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Tatyana Yatsunenko, Jonathan Lawrence, Madeline Rosini, Max Hecht, Christopher Matthew Liu
  • Glycan therapeutics and method of treating conditions associated with TMAO
    Patent number: 11229660
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: January 25, 2022
    Assignee: Kaleido Biosciences, Inc.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF
    Publication number: 20210401861
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements and medical foods thereof are provided, and methods of using said glycan therapeutics, e.g. in cancer therapy.
    Type: Application
    Filed: June 30, 2021
    Publication date: December 30, 2021
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Geoffrey A. von Maltzahn, Yvonne J. Yamanaka, Jared Silverman, John Miles Milwid, Jacob Rosenblum Rubens, John M. Geremia
  • Oligosaccharide compositions and methods of use thereof
    Patent number: 11169101
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of related diseases.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: November 9, 2021
    Assignee: Kaleido Biosciences, Inc.
    Inventors: Christopher Matthew Liu, Anastasia Lioubomirov, John M. Geremia, Mitchell Antalek, Jonathan Lawrence, Tatyana Yatsunenko, Brian Meehan
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF FOR REDUCING AMMONIA LEVELS
    Publication number: 20210198302
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of hyperammonemia-related diseases (e.g., urea cycle disorders and hepatic encephalopathy).
    Type: Application
    Filed: August 21, 2019
    Publication date: July 1, 2021
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Christopher Matthew Liu, John M. Geremia, Anastasia Lioubomirov, Max Hecht
  • OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20210164926
    Abstract: Aspects of the disclosure relate to oligosaccharide compositions and methods of making the same. Also provided are methods of using oligosaccharide compositions as microbiome metabolic therapies for reducing ammonia levels and for the treatment of related diseases.
    Type: Application
    Filed: January 25, 2021
    Publication date: June 3, 2021
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Christopher Matthew Liu, Anastasia Lioubomirov, John M. Geremia, Mitchell Antalek, Jonathan Lawrence, Tatyana Yatsunenko, Brian Meehan
  • GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF
    Publication number: 20210113596
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Application
    Filed: May 26, 2020
    Publication date: April 22, 2021
    Applicant: Kaleido Biosciences, Inc.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • Glycan therapeutic compositions and related methods thereof
    Patent number: 10894057
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements and medical foods thereof are provided, and methods of using said gycan therapeutics, e.g. in cancer therapy.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: January 19, 2021
    Assignee: Kaleido Biosciences, Inc.
    Inventors: Geoffrey A. von Maltzahn, Yvonne J. Yamanaka, Jared Silverman, John Miles Milwid, Jacob Rosenblum Rubens, John M. Geremia
  • Glycan therapeutics and related methods thereof
    Patent number: 10881676
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: January 5, 2021
    Assignee: Kaleido Biosciences, Inc.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • Glycan therapeutics and related methods thereof
    Patent number: 10702542
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: July 7, 2020
    Assignee: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • Glycan therapeutics and related methods thereof
    Patent number: 10314853
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: June 15, 2017
    Date of Patent: June 11, 2019
    Assignee: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • GLYCAN THERAPEUTIC COMPOSITIONS AND RELATED METHODS THEREOF
    Publication number: 20180147221
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements and medical foods thereof are provided, and methods of using said gycan therapeutics, e.g. in cancer therapy.
    Type: Application
    Filed: April 23, 2016
    Publication date: May 31, 2018
    Applicant: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Yvonne J. Yamanaka, Jared Silverman, Jack Milwid, Jacob R. Rubens, John M. Geremia
  • Glycan therapeutics for reducing blood ammonia
    Patent number: 9901595
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: February 27, 2018
    Assignee: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • Glycan therapeutics and related methods thereof
    Patent number: 9757403
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: September 12, 2017
    Assignee: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • Glycan therapeutics and related methods thereof
    Patent number: 9492473
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: November 15, 2016
    Assignee: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia
  • GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF
    Publication number: 20160213702
    Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
    Type: Application
    Filed: February 5, 2016
    Publication date: July 28, 2016
    Applicant: KALEIDO BIOSCIENCES, INC.
    Inventors: Geoffrey A. von Maltzahn, Jared Silverman, Yvonne J. Yamanaka, John Miles Milwid, John M. Geremia